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Abstract: (1) Background: Appetite loss in older people, the ‘Anorexia of Aging’ (AA), is common,
associated with under-nutrition, sarcopenia, and frailty and yet receives little attention. This review
had two aims: describe interventions for AA and their effectiveness, and identify the methods of
appetite assessment. (2) Methods: Study inclusion: participants aged ≥65, intervention for AA,
and appetite assessment, any design, and comparator. Exclusion: studies on specific health cohorts.
Searches in four databases with hand searching of references and citing works. Two researchers
independently assessed eligibility and quality. (3) Results: Authors screened 8729 titles, 46 full
texts. Eighteen articles were included describing nine intervention types: education (n = 1), exercise
(n = 1), flavor enhancement (n = 2), increased meal variety (n = 1), mealtime assistance (n = 1),
fortified food (n = 1), oral nutritional supplement (ONS) (n = 8), amino acids (n = 1), and medication
(n = 2). Three studies evaluated combinations: education + exercise, ONS + exercise, and ONS +
medication. Five intervention types exhibited favorable effects on appetite but in single datasets or
not replicated. Appetite was assessed predominantly by Likert (n = 9), or visual analogue scales
(n = 7). (4) Conclusions: A variety of interventions and methods of appetite assessments were used.
There was a lack of clarity about whether AA or undernutrition was the intervention target. AA is
important for future research but needs standardized assessment so that effectiveness of a range of
interventions can be fully explored.
Keywords: appetite; anorexia; treatment; assessment; older people; frailty; nutrition; systematic review
1. Introduction
The loss of appetite experienced by older people has been largely attributed to the aging process
and is often termed the ‘anorexia of aging’ (AA) [1]. The reported prevalence of AA ranges from up to
25% in home dwellers to 62% in hospital populations and 85% in nursing home populations [2].
AA has been linked to a number of important sequelae, predominantly due to poor oral intake
and reduction in a variety of nutrients including protein, fiber, whole grains, fruits, and vegetables [3,4].
The consequences of AA include the development of subsequent undernutrition, immunosuppression,
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sarcopenia, and frailty (which can reciprocally worsen appetite further). This ultimately leads to
adverse outcomes with higher rates of morbidity and mortality [3,5–8]. The causes of AA include
changes in peripheral hormone signaling, gut motility, and sensory perception due to aging as well as
social and environmental factors (Figure 1) [2,8–16].
Nutrients 2018, 10, x FOR PEER REVIEW  2 of 20 
 
AA has been linked to a number of important sequelae, predominantly due to poor oral intake 
and reduction in a variety of nutrients including protein, fiber, whole grains, fruits, and vegetables 
[3,4]. The consequences of AA include the development of subsequent undernutrition, 
immunosuppression, sarcopenia, and frailty (which ca  reciprocally worsen appe ite further). This 
ultimately leads to adverse outcom  with higher rates of morb dity and mortality [3,5–8]. The causes 
of AA include changes in peripheral hormone signaling, gut m tility, and se sory perception due to 
aging s w ll as social and environmental factors (Figure 1) [2,8–16]. 
 
Figure 1. Multi-factorial causes of the anorexia of aging. Consequences are mostly attributable to 
subsequent undernutrition but there is some evidence for an independent association with sarcopenia 
[2,8–16]. 
The terms undernutrition and AA are often used interchangeably, rather than the former being 
recognized because of the other. Currently, clinical efforts are concentrated more on identifying 
patients at risk of undernutrition, with AA receiving little attention. Undernutrition screening tools 
such as the Mini-Nutritional Assessment Short Form (MNA-SF) and Malnutrition Universal 
Screening Tool (MUST) are based on body mass index as well as weight loss and dietary intake, which 
are parameters that are also often thought of as a marker of appetite [17–22]. This lack of distinction 
between AA and undernutrition has led to research overlap with studies looking to address AA but 
then defining participants and intervention targets in terms of weight loss and oral intake rather than 
appetite assessment [18,22]. However, the amount a person consumes may also be subject to other 
factors such as masticatory, functional ability, and environmental factors rather than appetite alone, 
and so can be misleading [18]. 
To enable accurate identification of AA, appetite needs to be assessed. However, this is not 
routinely done in clinical practice. Different appetite assessments have been devised for research in 
both over-nutrition and under-nutrition [7,23–26]. Currently, it is unclear which method is best to use 
when evaluating clinical outcomes and treatment efficacy for the older population. Accurate 
. ulti-factorial causes of the anorexia of aging. Co seque c s ar mo tly attribu able to subsequent
undern tritio but the e is some evidence for an indep ndent association with sar openia [2,8–16].
The terms undernutrition and AA are often used interchangeably, rather than the former being
recognized because of the other. Currently, clinical efforts are concentrated more on identifying patients
at risk of undernutrition, with AA receiving little attention. Undernutrition screening tools such as
the Mini-Nutritional Assessment Short Form (MNA-SF) and Malnutrition Universal Screening Tool
(MUST) are based on body mass index as well as weight loss and dietary intake, which are parameters
that are also often thought of as a marker of appetite [17–22]. This lack of distinction between AA
and undernutrition has led to research overlap with studies looking to address AA but then defining
participants and intervention targets in terms of weight loss and oral intake rather than appetite
assessment [18,22]. However, the amount a person consu es may also be subject to other factors such
as masticatory, functional ability, and environmental factors rather than appetite alone, and so can be
misleading [18].
To enable accurate identification of AA, appetite needs to be assessed. However, this is not
routinely done in clinical practice. Different appetite assessments have been devised for research in
both over-nutrition and under-nutrition [7,23–26]. Currently, it is unclear which method is best to use
when evaluating clinical outcomes and treatment efficacy for the older population. Accurate assessment
of AA and a focus on interventions, particularly prior to significant weight loss, could potentially be
an approach to prevent the onset of undernutrition and slow the frailty trajectory [26].
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This systematic review had two aims. The first aim was to describe current interventions for
AA and their reported effectiveness in the older population, and the second aim was to identify the
methods of the appetite assessment used.
2. Materials and Methods
This systematic review was carried out using the methods recommended by the Preferred
Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement [27]. The review was
registered on the international prospective register of systematic reviews (PROSPERO) ID number:
CRD42018096302. The full protocol is available upon request.
2.1. Study Inclusion
The criteria for inclusion is presented in Figure 2. Articles relating to studies with any design
or setting were included if they measured appetite (even if it was not the primary outcome),
in people with a mean age of 65+ years and described a treatment for AA. Due to the amount
of interchangeability between the terminology of undernutrition and AA, studies reporting an
intervention for undernutrition (also termed malnutrition) that assessed the appetite were included.
Articles in any language were considered.
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Studies focusing on a cohort with a specific physical or mental health condition known to
impact on appetite (including cancer, chronic obstructive pulmonary disease (COPD), heart failure,
renal failure, depression, anorexia nervosa, and dementia) were excluded. Studies focusing on
understanding the physiological echanis s of ere also excluded.
2.2. Data Collection
A search was run in four online databases: EMBASE and MEDLINE via the OVID SP platform,
the Web of Science and CINAHL via the EBSCO platform. The searches were run from database
conception until 11 May, 2018 with no limits on the publication type. An example search strategy for
the MEDLINE search is included (Appendix A).
Screening of titles and then abstracts for relevance was performed independently by two authors
(N.J.C. and K.I.) using the Rayyan electronic platform [28]. Following each stage, there were conferring
and disputed texts that were taken forward to the next stage. Full texts of potentially relevant abstracts
were reviewed against inclusion and exclusion criteria. Hand searching of the reference list and citing
works of included texts and relevant reviews was completed. All articles arising from a single dataset
were evaluated and the most comprehensive article related to appetite assessment was included.
2.3. Data Analysis
Data from included studies were abstracted into a pre-defined template (designed by N.J.C.). Authors
were contacted to obtain further information. Publication quality was assessed using the standardized
Joanna Briggs Institute checklists for each study type giving a total score of 13 for randomized controlled
trials (RCTs), nine for quasi-experimental studies, and 10 for qualitative studies [29].
Nutrients 2019, 11, 144 4 of 20
3. Results
The initial search identified 8729 articles following removal of duplicates. All titles were screened
for relevance and 403 abstracts were reviewed. Forty-six full text articles were reviewed with 18 studies
meeting inclusion criteria [30–47]. A summary of screening and eligibility is included in Figure 3.
Figure 3. Flow diagram for screening and eligibility of studies for inclusion.
The reporting format consisted of 17 journal articles and one conference abstract [36]. Quality scores
ranged from 5/13 to 13/13 for RCTs (the conference abstract scored poorly due to insufficient data),
9/9 for all within subject designs, and 8/10 for the qualitative study (Appendix B). No studies were
excluded following quality assessment [30–47].
From the 18 included studies, nine different types of intervention for AA were identified.
These were grouped into categories devised by the authors, judged on clinical relevance and similarity.
The authors accept that there are alternative ways in which the interventions could be grouped but this
method enabled synthesis with a clinical focus (Table 1). Due to the heterogeneity of study methodology
and results, a meta-analysis was unachievable. Results are presented as a narrative synthesis of study
characteristics including treatment strategies for AA with a reported effect on appetite and then
methods were used to assess appetite. A summary of the included studies, grouped by intervention
category, is provided (Table 2).
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Table 1. Categorization of types of intervention for anorexia of aging with included studies.
Intervention Category
(Number of Studies) Intervention Type with Included Studies
Education (n = 1) Nutritional counselingAndersson et al. [30]
Exercise (n = 1) Exercise programDe Jong et al. (arm 1) [34]
Meal Adjustments (n = 4)
Flavor enhancement
Best et al. [46]
Mathey et al. [39]
Increased meal variety
Wijnhoven et al. [44]
Mealtime volunteer assistance
Robison et al. [42]
Supplementation (n = 10)
Oral nutritional supplement
Boudville et al. [31]
Carlsson et al. (arm 1) [33]
De Jong et al. (arm 2) [34]
Faxen-Irving et al. [35]
Hubbard et al. [36]
Irvine et al. [37]
Ryan et al. [43]
Tylner et al. [47]
Amino acid pre-cursor
Brocker et al. [32]
Fortified Food
Pouyssegur et al. [40]
Medication (n = 2)
Medication (megestrol acetate)
Reuben et al. [41]
Yeh et al. [45]
Combinations (n = 3)
Education & exercise
Kimura et al. [38]
Exercise & oral nutritional supplement
De Jong et al. (arm 3) [34]
Oral nutritional supplement & medication (nandrolone decanoate)
Carlsson et al. (arm 2) [33]
3.1. Study Characteristics
The studies were comprised of 12 randomized controlled trials, five within subject design studies
(participants receiving both intervention and control), and one qualitative study [30–47]. A number of
countries were represented including the United States, United Kingdom, France, The Netherlands,
Sweden, Norway, Australia, and Japan. The sample populations were from our own home (n = 6),
care home (n = 6), acute hospital (n = 5), and rehabilitation (n = 3) (some studies drew their sample
from multiple settings. See Table 2) [30–47]. Two studies followed participants across settings: one
from rehabilitation to their own home [30], and one from a hospital stay and into the community [33].
The studies totaled 1115 participants with individual sample sizes ranging from 12 to 185 and
a mean age range of 74–87 years [30–47]. Sixteen studies reported the mean body mass index (BMI)
of participants, which ranged from 19.3 to 30 but was mostly below 25 [30–41,43,44,46,47]. Seventeen
of the study samples were defined as being either undernourished (using nutritional assessment
tools, BMI, or weight loss) or having a self-reported poor appetite at baseline [30–45,47]. Only four
studies [31,32,41,44] reported eating difficulty or artificial feeding as exclusion criteria. Samples were
predominantly female with only three studies recruiting mostly men [37,43,45]. Two studies did not
report the sex of participants [32,36].
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Table 2. Summary of included studies grouped by intervention category.
Author, Reference,
Year, Country
Study Design &
Intervention Length
Setting &
Participants Age *
Appetite Assessment
(Time Points Measured) Intervention Control Effect on Appetite
Andersson et al. [30]
2017
Norway
Open RCT
(3 months)
Rehabilitation + Own
home
N = 100, F # = 62%
BMI * = 20.2 (3.3)
75 (8.7)
DRAQ
10 item Likert 1–5
(Recruitment, 3 months)
Education:
-Nutrition plan pre-discharge
and counseling post discharge
Usual care No change(p > 0.05)
Best et al. [46]
2011
United Kingdom
Within subject design
(3 sessions)
Own home
N = 18, F # = 77%
BMI * = 30 (U/K)
77
(U/K)
Likert scale 1–5:
Hunger, desire to eat
(Pre-test and post-test
meal)
Meal adjustment:
-Seasoning (2 spoonful’s of
choice of branded recipe)
-Sauce (100 g of choice of
branded recipe)
Control meal:
-Same basic meal
constituents
No change pre or post
meal
Hunger (p = 0.28,
p = 0.65)
Desire to eat (p = 0.36,
p = 0.15)
Mathey et al. [39]
2001
Netherlands
Open RCT
(17 weeks)
Care home
N = 42, F # = 76%
BMI * = 28.3 (7.2)
79 (5.6)
AHSPQ
29 item Likert 1–5
(Recruitment, 17 weeks)
Meal adjustment:
-Flavor enhancement with
four flavors containing MSG
Usual care
Increase vs. control and
from baseline in daily
feelings of hunger
(p < 0.05)
Wijnhoven et al. [44]
2015
Netherlands
Within-subject design
(2 sessions)
Own home + care
home
N = 19, F # = 100%
BMI * = 24.8 (4.9)
84 (8)
Likert scale 1–9:
Appetite, satiation
(Pre and post test meal)
Meal adjustment:
-Increased variety with three
different varieties of
meat/fish, vegetable & starch
on one plate
Control meal:
-One variety of
components on
one plate
No change
(p not reported)
Robison et al. [42]
2014
United Kingdom
Qualitative study
(1 year)
Hospital
N = 25, F # = 100%
BMI * = U/K
U/K
Individual
semi-structured
interviews
(Purposive sample
pre-intervention, 1 year)
Meal adjustment:
-Mealtime volunteer
assistance during a meal
Usual care No change(Qualitative method)
Boudville et al. [31]
2004
Australia
Within-subject design
(2 sessions)
Rehabilitation
N = 14, F # = 100%
BMI * = 22.6(3.4)
79 (7.5)
Likert scale 0–5:
Hunger, thirst, fullness,
prospective consumption,
nausea
(Pre and post drink and
pre and post meal)
Supplementation:
ONS
-250 mL liquid 90 or 30 min
pre-meal (250 Kcal/24 h)
250 mL water:
-pre-meal
No change
(p not reported)
Faxen-Irving et al. [35]
2011
Sweden
Open RCT
(8 days)
Hospital
N = 51, F # = 53%
BMI * = 21.3(3.7)
84(7)
VAS 10 point:
hunger, fullness, desire to
eat, prospective
consumption,
preoccupation with food
(Recruitment, 8 days)
Supplementation:
ONS
-3 × 30 mL fat emulsion
based liquid with
medications (419.4
Kcal/24 h)
Usual care
Increase vs. control in
desire to eat
(p = 0.021)
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Table 2. Cont.
Author, Reference,
Year, Country
Study Design &
Intervention Length
Setting &
Participants Age *
Appetite Assessment
(Time Points Measured) Intervention Control Effect on Appetite
Hubbard et al. [36]
2008
United Kingdom
RCT
(4 weeks)
Community
(Undefined)
N = 42, F # = U/K
BMI * = 20.9(3.5)
84 (7)
VAS 10 point:
hunger, fullness, and
desire to eat
(Recruitment, 4 weeks)
Supplementation:
ONS
-3 × 30 mL liquid
(400 Kcal/24 h)
Standardized
dietary advice
sheet
No change
(p not reported)
Irvine et al. [37]
2004
France
Within-Subject design
(3 days)
Hospital
N = 12, F # = 33%
BMI * = 21.3(2.4)
87
(7.8)
VAS 100 point:
Hunger, fullness, desire to
eat, preoccupation with
food, thirst, cold.
(Every 30 min (t = 0 h) to
lunch (t = 4.5 h), then
hourly to dinner
(t = 10.5 h))
Supplementation:
ONS
-250 mL liquid
post-breakfast, High protein
(HP) or low protein
(LP) content
(250 Kcal/24 h)
Usual care
Decrease in hunger
pre-lunch, not
pre-dinner for HP
(p = 0.01)
Non-significant for LP
(p = 0.1)
Ryan et al. [43]
2004
France
Within-Subject design
(3 days)
Hospital
N = 16, F # = 38%
BMI * = 20(3)
77 (8)
VAS 100 point:
Hunger, satiety, desire to
eat, preoccupation with
food, thirst, stress, cold.
(Every 30 min (t = 0 h) to
lunch (t = 4.5 h), then
hourly to dinner
(t = 10.5 h))
Supplementation:
ONS
-250 mL liquid
post-breakfast, High fat (HF)
or high carbohydrate
(HC) content
(250 Kcal/24 h)
Usual care
Decrease in hunger
pre-lunch, not
pre-dinner for HF
(p = 0.04)
Non-significant for HC
(p = 0.13)
Tylner et al. [47]
2016
Sweden
Open RCT with
crossover
(12 weeks)
Care home
N = 39, F # = 60%
BMI * = 23(3.7)
84 (7)
VAS 10 point:
hunger, fullness, desire to
eat, prospective
consumption,
preoccupation with food
(Recruitment, 6, 12 weeks)
Supplementation:
ONS
-3 × 30 mL fat emulsion
based liquid with
medications (360 Kcal/24 h)
Usual care
Increase vs. control in
hunger
(p = 0.026)
Brocker et al. [32]
1994
France
Double blind placebo
RCT
(4 months)
Own home
N = 185, F # = U/K
BMI * = calculated
Approx 19
74
(7.4)
VAS 100 point:
appetite to meat, overall
appetite
(Recruitment, 30 and
60 days)
Supplementation:
Amino acid pre-cursor
-Ornithin Oxoglutarate 10 g
in morning
Placebo:
-Maltodextrine
(same energy
content)
Increase vs. control
30 days appetite for
meat (p = 0.001) &
overall appetite
(p = 0.001)
60 days appetite for
meat (p < 0.001) &
overall appetite
(p < 0.001)
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Table 2. Cont.
Author, Reference,
Year, Country
Study Design &
Intervention Length
Setting &
Participants Age *
Appetite Assessment
(Time Points Measured) Intervention Control Effect on Appetite
Pouyssegur et al. [40]
2015
France
Open RCT
(6 weeks)
Care home
N = 154, F # = 80%
BMI * = 19.2(2.9)
86
(7.1)
VAS 10 point:
overall appetite
(Recruitment, 18 weeks)
Supplementation:
Fortified food
-8 cookies (244 Kcal/24 h)
Usual care Increase from baseline(p = 0.009)
Reuben et al. [41]
2005
United States of
America
Double blind placebo
RCT
(63 days)
Care home +
rehabilitation
(Recent hospital
discharge)
N = 45, F # = 66%
BMI * = 22.6(U/K)
82 (U/K)
Likert scale 0–5 or 0–4:
Appetite, appetite at start
of last meal, hunger at
start of last meal
(Recruitment 20, 42, and
63 days)
Medication:
-Megestrol Acetate, 200 or 400
or 800 mg/24/h
Placebo
(undefined)
No change vs. control.
(p = 0.07)
Increase from baseline
in overall appetite at 20
days (p = 0.04), appetite
at start of least meal at
42 days (p = 0.02)
Yeh at al. [45]
2000
United States of
America
Double blind placebo
RCT
(12 weeks)
Care home
N = 51, F # = 5%
Weight loss of >5%,
or weight 20%
below IBW
76 (1.3)
Likert scale 1–5:
Overall appetite
(Recruitment, 12 weeks)
Medication:
-Megestrol Acetate,
800 mg/24 h
Placebo
(undefined)
Increase vs. control in
overall appetite
(p = 0.004)
Kimura et al. [38]
2013
Japan
Cluster RCT
With crossover
(14 months)
Own home
N = 92, F # = 80%
BMI * = 24.3 (2.9)
74 (5.6) Questionnaire “yes/no”(Recruitment, 14 months)
Combination-education +
exercise:
-Dietary Advice
-Muscle strengthening 1 h
every 2 weeks + self-directed
at home
Usual care No change(p = 1.0)
de Jong et al. [34]
1999
Netherlands
Open RCT
(17 weeks)
Own home
N = 165, F # = 68%
BMI * = 23.6(2.7)
79 (3.6) AHSPQ29 item Likert 1–5(Recruitment, 17 weeks)
Combination-supplementation
+/or exercise:
-Micronutrient dense ONS
(114 Kcal/24 h).
-Muscle strength,
coordination, flexibility,
endurance 45 min twice a
week
Regular ONS
(same energy) and
social program:
-90 min every two
weeks
No significant change
for Exercise (p = 0.61),
ONS (p = 0.17) or
Combination (p not
reported)
Carlsson et al. [33]
2005
Sweden
Open RCT
(6 months)
In hospital + discharge
out to community
N = 45, F # = 100%
BMI * = 20.4(2)
83 (5)
Likert scale 0–4: overall
appetite
(Recruitment, 6 months)
Combination-supplementation
+/- medication:
-ONS liquid protein rich
(200 Kcal/24 h),
-nandrolone decanoate
25 mg/3 weekly
Usual care
No change for ONS and
ONS + medication
versus control
(p not reported)
Increase from baseline
for ONS + medication
(p = 0.02)
* Reported as mean (Standard deviation), # Percentage of participants female; BMI = body mass index, RCT = randomized controlled trial, DRAQ = Disease Related Appetite Questionnaire,
U/K = unknown, AHSPQ = Appetite, Hunger, Sensory Perception Questionnaire, MSG= monosodium glutamate, VAS = Visual analogue scale, ONS = oral nutritional supplement,
IBW= ideal body weight.
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3.2. Treatment Strategies for Anorexia of Aging and Reported Effect on Appetite
Included studies reported on a range of interventions for AA. The nine different types of
intervention have been broadly categorized by the authors into education, exercise, meal adjustments,
supplementation, and medications (Table 1). Some of the interventions were used in combination.
When reported individually for a study arm, effects on appetite are described individually. Otherwise,
they are described for the combination (Table 1).
3.2.1. Education (n = 1)
Andersson et al. assessed a three-month education program [30]. This entailed an individual
nutritional plan for dietary requirements and intake pre-discharge from the hospital and then
post-discharge counseling [30]. Counseling addressed the eating environment, motivation, and support
to increase intake, food preparation, food choices, and also undefined social and psychological
factors [30]. Thirteen percent of participants were lost to follow up and comply with the intervention,
which was assessed but not stated. There was no significant effect on appetite when compared to a
control group receiving the usual care (p > 0.05) [30].
3.2.2. Exercise (n = 1)
The first arm of de Jong et al. [34] considered a 17-week community based exercise program.
This required 45-min group sessions twice a week focusing on muscle strength, coordination, flexibility,
and endurance [34]. Compliance and physical activity levels during the intervention were not assessed.
The authors reported no effect on appetite compared to controls attending a class with creative activities
(p = 0.61) [34].
3.2.3. Meal Adjustments (n = 4)
Four studies adjusted the participant’s meal or mealtime [39,42,44,46]. Mathey et al. [39] used
flavor enhancement with four different flavors (chicken, beef bouillon, turkey, and lemon butter for
fish) depending on the meal constituents, all of which contained monosodium glutamate. This was
sprinkled over the entire main meal for 17 weeks in a care home. The authors reported increased
daily feelings of hunger among participants, compared to controls having the usual meal and with
the participant’s baseline appetite (p < 0.05) [39]. Increasing the flavor of meals was also studied by
Best et al. on a community dwelling of older people [46], who used seasoning on one occasion (two
spoonfuls of a choice of branded recipe) or sauce on another (100 g of a choice of branded recipe)
on a meal of chicken, vegetables, and mashed potato [46]. In comparison to a control meal of the
same ingredients, there was no difference in pre or post meal appetite domains of ‘hunger’ or ‘desire
to eat’ (hunger p = 0.28, p = 0.65, desire to eat p = 0.36, p = 0.15) [46]. Wijnhoven et al. [44] changed
the constituents of single meals to increase their variety for community dwellers. Meals with greater
variety had three different selections of vegetables of three different colors, three different types of
meat (or fish), and three different types of starch all-together on one plate. They reported no change
in appetite compared with a control meal of only one variety of vegetable, meat, and starch (P not
reported) [44].
Robison et al.’s qualitative study [42] explored the effect of one year of trained mealtime volunteer
assistants helping hospital patients to eat on their appetite and food intake. The impact of mealtime
assistants on appetite was not reported, but themes of poor appetite were prevalent in interviews from
both the pre and post intervention samples with no apparent improvement following volunteer help [42].
3.2.4. Supplementation (n = 10)
Supplementation included oral nutritional supplements (ONS), an amino acid-precursor, and
fortified food. ONS were assessed in eight studies (an individual arm of two) [31,33–37,43,47]. All ONS
differed in constituents when specified and included fatty emulsion, high protein, low protein, high fat,
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high carbohydrate, and micronutrient dense formulas [31,33–37,43,47]. The total 24-h energy content
ranged from 200–419 Kcal in 250 mL or 30 mL portions. None of the ONS were directly comparable in
terms of constituent ingredients, energy content, and volume [31,33–37,43,47]. ONS showed mixed
effects on appetite. No effect was seen for ONS with unspecified constituents (p values not reported)
or high in micronutrients (p = 0.17) when compared to controls receiving usual care or standardized
dietary advice sheets [31,34,36]. In Carlsson et al.’s study, the arm investigating individuals’ effects of a
high protein ONS [33] reported no effect on appetite compared with controls receiving the usual care at
six months (p value not reported) [33]. An increase in the appetite domains ‘desire to eat’ and ‘hunger’
were reported in two different studies using fat emulsion ONS, compared to controls receiving usual
care (desire to eat p = 0.021 [35], ‘hunger’ p = 0.026. [47]). A transient decrease in the domain of ‘hunger’
following a high fat and a high protein ONS after 4.5 h when compared to participant’s baseline was
reported by Ryan et al. (p = 0.04) [43] and Irvine et al. (p = 0.01) [37], respectively. This did not persist
in measurements at later time points [37,43]. Three of the studies using ONS reported a loss to follow
up of participants due to product intolerance (numbers not specified) [35,37,43].
Brocker et al. evaluated the amino acid pre-cursor, ornithin oxoglutarate [32]. Home dwellers
following recent hospital discharge were given 10 g once a day with controls receiving placebo [32].
An increase in the appetite domains ‘overall appetite’ and ‘appetite for meat’ was observed when
compared to controls at 60 days (p < 0.001, p < 0.001) [32]. Pouyssegur et al. [40] assessed fortified
food for care home residents, in the form of cookies between meals delivering 244 Kcal energy in
24 h. The authors reported an increase in the ‘appetite’ domain after 18 weeks when compared to
participant’s baseline (p = 0.009) [40].
3.2.5. Medications (n = 2)
The effect on appetite of the progestogen medication megestrol acetate (MA) was evaluated in two
double blind placebo RCTs including one on care home residents and another on community dwellers
following recent hospital discharge [41,45]. MA was prescribed in either 200, 400, or 800 mg doses
over 24 h with mixed results. At doses of 800 mg, when compared to controls, Yeh et al. described
an increase in appetite at 12 weeks (p = 0.004) [45] while Reuben et al. observed no difference when
compared to controls at three or six weeks for the range of doses from 200 to 800 mg (p = 0.07) [41].
Reuben et al. did, however, report an increase from the participant’s baseline in the domains of
‘appetite’ and ‘appetite at start of last meal’ with the 800 mg and 400 mg doses, respectively (p = 0.04,
p = 0.02) [41]. The authors discussed adverse outcomes. Reuben et al. reported significantly lower
cortisol levels compared to controls at 20 days (400 mg p = 0.003, 800 mg p = 0.02) but no clinical
symptoms of adrenal insufficiency [41]. They also observed venous thromboembolism (n = 2) and
diarrhea (n = 3) [41]. Yeh et al. reported no statistically significant differences compared to controls for
events related to drug therapy, and no significant difference on mortality (p values not reported) [45].
3.2.6. Combined Interventions (n = 3)
Kimura et al. [38] evaluated the combination of exercise and education for home-owning dwellers
over a 14-month period. This comprised of one-hour exercise classes every two weeks focusing on
muscle strengthening, with at-home exercise recommendations and daily recording with feedback.
Alongside were five 30-min lectures on dietary habits with participants recording daily intake,
which was reviewed with motivational comments [38]. The authors found no change in appetite in the
intervention group, compared to controls receiving usual care (p = 1.0) [38].
The third arm of the de Jong et al. study evaluated 17 weeks of micronutrient dense ONS in
combination with the described exercise program [34]. There was no change in appetite compared to
controls receiving regular products and classes with creative activities (p value not reported) [34].
The effect of a protein rich ONS (244 Kcal in 24 h) in combination with the anabolic steroid
nandrolone decanoate (25 mg every three weeks) was assessed in a second arm of Carlsson et al. [33].
They observed no difference in appetite compared to controls receiving usual care (p not reported) but
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an increase from baseline appetite assessment for six of the 15 participants having the combination
(p = 0.02) [33]. Adverse incidents relating to nandrolone decanoate were not reported in the article [33].
An article on the same study cohort noted a transient rise of serum calcium, which reverted without
therapy change, and incidence of urinary tract infections. A diagnosis was also present in the control
group with no measure of difference between the two [48].
3.3. Methods of Appetite Assessment
A range of methods were used to assess appetite among studies that could be categorized into
Likert scales, visual analogue scales (VAS), and a qualitative method. All of the studies assessed the
participant’s appetite at recruitment. Subsequent assessment then ranged from immediately post
intervention (e.g., immediately post meal consumption) to 14 months for the longest intervention.
There was no association between settings, timing of measurement or type of intervention, and the
appetite assessment used [30–45].
3.3.1. Likert Scales
Nine studies used the Likert scale method to assess appetite. Andersson et al. [30] used the Disease
Related Appetite Questionnaire (DRAQ). This questionnaire, based on the Council on Nutrition Appetite
Questionnaire (CNAQ), was created for COPD patients [26,30,49]. The DRAQ contains 10 domains each
using a five point Likert scale. Domains included semi-quantification of appetite, day-to-day variations
in appetite, food tastes, frequency of eating, presence of nausea, and impact of mood or co-existing
disease on food intake with a maximum score of 50 corresponding to a good appetite.
Mathey et al. [39] and de Jong et al. [34] both assessed appetite with the Appetite, Hunger, and
Sensory Perception Questionnaire (AHSPQ). This 29 domain questionnaire, using a five-point Likert
scale, correlates with weight change in a community dwelling among older people [50], and in the de
Jong study correlated with self-reported energy intake by participants (p < 0.0002) [34]. Domains are
grouped into the present taste perception, the present smell perception, the present smell perception
compared with the past, appetite, and daily feelings of hunger. A maximum score of 145 corresponds
to positive feelings.
A further six studies used unnamed Likert scales to assess appetite [31,33,41,44–46]. The scales
had differing domains. These included ‘overall appetite,’ ‘appetite at the start of the last meal,’ ‘hunger,’
‘hunger at the start of the last meal,’ ‘thirst,’ ‘fullness/satiation,’ ‘prospective consumption,’ and ‘desire
to eat.’ The domain of ‘overall appetite’ was used widely but no domain was common to all six of
these Likert scales. The Likert scales also varied in the number of rating points, ranging from five to
nine. There were no references to validity. Two had been used previously in healthy older men [31],
and a cancer cohort [45].
3.3.2. Visual Analogue Scales (VAS)
Seven studies assessed appetite by VAS [32,35–37,40,43,47]. These numerical scales were
reported in different ways as either 10-point or 100-point lengths. Multiple different domains were
measured including ‘overall appetite,’ ‘hunger,’ ‘fullness,’ ‘desire to eat,’ ‘prospective consumption,’
‘preoccupation with food,’ ‘thirst,’ ‘stress,’ and ‘cold’. The domains of ‘hunger,’ ‘fullness,’ ‘desire to
eat,’ and ‘preoccupation with food’ predominated but no domain was used across all seven studies.
Two studies screened participants on their ability to complete a VAS before inclusion but did not
report how many were excluded on this basis [37,43]. Three studies referenced the ability of their
VAS to predict oral intake in healthy young people [23,35,43,47], and one cited oral intake in a cancer
cohort [40,51].
3.3.3. Qualitative Approach
Robison et al. [42] assessed subjective appetite perceptions by semi-structured interviews.
The interviews broadly covered the topics of appetite, choosing what to eat, managing at mealtimes and
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food, and fluid intake during the hospital stay [42]. The authors used prompts to explore interviewee’s
experiences pre and post intervention. Framework thematic analysis then captured the range of
perspectives [42].
3.3.4. Undefined Method
Kimura et al. [38] assessed appetite using an undefined method, which reported the outcome in a
‘yes/no’ nominal style and made no reference to the tool’s validity.
4. Discussion
This review identified 18 studies with an intervention for AA and appetite assessment enabling
evaluation of nine different intervention types to improve appetite [30–47]. These studies were
carried out in different countries with participants from different settings including hospital,
rehabilitation, care homes, and own home. The mean ages of participants were over 74 years with
a BMI predominantly below 25. The studies displayed heterogeneity in methodology, assessment,
and intervention type so pooling of the data for meta-analysis was not possible.
The nine different types of intervention for AA were broadly categorized into education (nutritional
counselling), exercise (exercise programs), meal adjustments (flavor enhancement, increased variety,
mealtime assistance), supplementation (ONS, amino acid precursor, fortified food), medication
(megestrol acetate or nandrolone decanoate medication) and combinations. Of the nine different types of
intervention, five exhibited some favorable effects on appetite (flavor enhancement, ONS, an amino acid
precursor, fortified food, and megestrol acetate medication) when compared to controls or from baseline.
However, findings were either in single datasets or not replicated across studies.
Appetite was assessed in a number of different ways, predominantly using Likert or visual analogue
scale methods but with a range of different domains and scoring systems. Some of the methods used
have been validated in older people, but generally methods were created for other populations.
This review has again highlighted that many studies combine the concepts of AA and
undernutrition. There was variation in the authors’ treatment intentions, whether AA or
undernutrition, when measuring appetite as an outcome. Appetite and outcome of oral intake when
measured were also often discussed together even though, largely, studies did not control for other
factors that may impact on eating such as masticatory ability or dysphagia. The terms undernutrition
and AA were often used interchangeably rather than undernutrition being recognized due to AA. Lack
of clarity on this is important since some people with AA may not yet be undernourished but rather be
at risk of developing it (as seen with Mathey et al.’s study sample, with a poor appetite, but a BMI > 25)
and so could be missed if undernutrition is the sole focus [26,39]. A focus on AA with treatment
of this specific group may reduce the onset of weight loss. However, currently there is a gap in the
literature on this sub-group, due to participants often being identified for study inclusion by poor oral
intake or weight loss. Observational data on the covariates of those with a poor appetite who are not
undernourished would be valuable, to fully understand this cohort and enable targeted interventions.
Among interventions for AA, the two studies addressing education and exercise did not suggest
any effect on appetite. However, the studies had significant limitations related to a lack of reporting of
compliance measures and levels of physical activity achieved for the exercise programs. Adjustments to
participant’s meals gave mixed results, but the introduction of flavor enhancers may have a beneficial
effect counteracting diminished sensory function attributable to aging to increase food palatability [39,52].
Studies assessing ONS were the largest sub-group, consistent with current clinical guidance on
the management of undernutrition. The effects on appetite were mixed, but there seems to be some
consensus that additional ONS only transiently reduces appetite, if at all [31,35–37,43]. This effect
on appetite is also reported in controlled studies assessing the physiology of AA, which reinforces
the view that addition of ONS increases overall energy intake [53–55]. However, losses to follow-up
due to product aversion occurred in ONS studies (numbers not reported) [35,37,43]. This finding is
in line with opinion that ONS can be poorly tolerated [56]. The amino acid precursor and fortified
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food studies both reported an increase in appetite [32,40]. Patients who were compared to ONS
better tolerate fortified food [57] and a potential associated increase in appetite suggests it warrants
further exploration.
The effect of medications was also considered in this review with evidence that megestrol acetate
(MA) had a stimulatory effect on appetite [41,45]. However, MA has been associated with safety
concerns in older people including adrenal suppression, venous thromboembolism, hyper- and
hypoglycaemia, changes in mental state, diarrhea, insomnia, and osteoporosis [41,58–60]. The side
effect profile of anabolic agents such as nandrolone decanoate, is also considerable, including fluid
retention, liver injury, and prostatic hypertrophy [59]. These findings caution against the use of these
medications for AA.
The lack of reproducibility for interventions trialed in more than one study may, in part, be due
to the need for multi-component interventions for AA, in view of the number and diversity causes
(Figure 1). Only three of the included studies combined interventions, all of which had just two
components and for the lifestyle interventions included limitations, which impacted on the assessment
of compliance and utility. There is currently a gap in the literature on multi-component interventions,
which aim to address different causes of appetite loss. This would be beneficial and may yield
positive results.
Appetite was assessed in different ways. Of the first main group, the Likert scales, the Appetite,
Hunger and Sensory Perception (AHSPQ) questionnaire has validity among community dwelling older
people correlating with weight change and self-reported intake [34,50]. However, it has subsequently
been shown to be difficult to adapt to undernourished older populations in different settings [61].
Thus, the Council on Nutrition Appetite Questionnaire (CNAQ) with its reliable shortened derivative,
the Simplified Nutritional Appetite Questionnaire (SNAQ) were developed from the AHSPQ and
have been shown to predict weight loss in community dwelling older people [26]. The SNAQ consists
of four domains: appetite, fullness, taste of food, and meal frequency. A score of ≤14 indicates a
risk of 5% weight loss in six months [26]. It has validity against the nutritional assessment tools
Subjective Global Assessment (SGA) and Mini-Nutritional Assessment (MNA) but may ‘over predict’
undernutrition [62,63]. This perhaps reflects the nature of the SNAQ as more of an appetite assessment
tool where a proportion of those with AA may not yet have experienced significant weight change,
but who, nevertheless, may proceed onto it. The SNAQ originated in a community setting but has
shown reliability, validity, and ability to predict inadequate intake and higher risk of morbidity
and mortality in the hospital setting [5,7,26,64]. The DRAQ [30] is based on the CNAQ but adds
disease-related questions since it was created for COPD patients, which makes it more relevant for
measuring appetite loss due to chronic disease rather than AA.
Visual analogue scales (VAS) were the other commonly used method of appetite assessment.
The VAS domains that show ability to predict eating behavior in older people are hunger, prospective
consumption, and fullness [24,25]. VAS have originated from the laboratory environment assessing
the physiological mechanisms of appetite control [13,24]. Studies included in this review, have also
shown VAS to be transferrable to the clinical environment [35,37,40,43]. However, screening of ability
to complete a VAS in two of the included studies suggested a potential limitation of its feasibility of
use for older people [37,43]. This has also been seen when VAS have been used for the assessment
of pain in older populations, and a high number of errors in completion have been reported [65].
These findings suggest that VAS may not be ideal in a clinical setting where staff need a quick and
easy tool.
This review has focused on appetite assessment methods for older people in the context of
an intervention. When looking at non-intervention studies, there is a large overlap in methods.
Most commonly used are semi-structured interviews [66–69], the CNAQ or SNAQ (including
different language derivatives) [5,7,70–77], and Likert scales with differing domains and rating
points [3,20,78–84]. Appetite can also be assessed as a part of some nutritional assessment tools
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such as the Short Nutritional Assessment Questionnaire 65+ (SNAQ 65+) [83] or MNA. However,
this can also add to the lack of clarity between AA and undernutrition.
Strengths and Limitations of the Review
This systematic review was carried out following the recommendations of the PRISMA
statement [27]. Two researchers worked independently to assess studies for inclusion and quality. Hand
searching was undertaken to ensure appropriate acquisition of studies and no limits on publishing
language were set. The authors of two included studies were also contacted with one response and
further information. However, the search did not include the grey literature where sources such as
service improvement projects may have been identified.
The included articles were of variable quality although the studies were representative of the
older population across settings. However, the interventions were variable and some were only
represented in single samples. Likewise, the appetite assessment tools used also varied and were often
not validated for use in older people.
5. Conclusions
The review identified only 18 studies with an intervention for AA and appetite assessment.
There was a lack of clarity about whether AA or undernutrition was the target of interventions.
Among a variety of intervention types, flavor enhancement, ONS, an amino acid precursor, fortified
food, and megestrol acetate showed a favorable effect on appetite but only in single datasets or
not reproduced across studies. Currently, the side effect profiles of medications studied and the
burden of polypharmacy among this population make this an unattractive option. However, flavor
enhancement and supplementation particularly in the form of fortified food could be potential avenues
of interest, together with a more rigorous assessment of the impact of lifestyle measures such as exercise.
The review identified four different methods of appetite assessment, which were predominantly Likert
and visual analogue scales but in a variety of forms. AA is an important area for future research
but assessment needs to be standardized so that the effectiveness of a range of interventions can be
fully explored.
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Appendix A. Search Strategy for MEDLINE on OVID SP Platform
1. exp AGED/
2. elder*.mp.
3. older.mp.
4. geriatric*.mp.
5. 1 or 2 or 3 or 4
6. exp THERAPEUTICS/
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7. Disease Management/
8. treat*.mp.
9. interven*.mp.
10. manag*.mp.
11. 6 or 7 or 8 or 9 or 10
12. APPETITE/
13. Appetite Regulation/
14. ANOREXIA/
15. appetite.mp.
16. anorexia.mp.
17. unplanned weight loss.mp.
18. 12 or 13 or 14 or 15 or 16 or 17
19. 5 and 11 and 18
20. exp NEOPLASMS/
21. cancer*.mp.
22. neoplas*.mp.
23. malignan*.mp.
24. carcinoma*.mp.
25. 20 or 21 or 22 or 23 or 24
26. 19 not 25
27. Anorexia Nervosa/
28. anorexia nervosa.mp.
29. 27 or 28
30. 26 not 29
31. child*.mp.
32. 30 not 31
33. Animals/not (Animals/and Humans/)
34. 32 not 33
Appendix B.
Table A1. Quality assessment using Joanna Briggs Institute checklist for study design.
Author, Year of Publication, Ref JBI Checklist Used Score/Max Score
Andersson et al., 2017, [30] RCT 11/13
Best et al., 2011, [46] NRES 9/9
Boudville et al., 2004, [31] NRES 9/9
Brocker et al., 1994, [32] RCT 13/13
Carlsson et al., 2005, [33] RCT 9/13
de Jong et al., 1999, [34] RCT 9/13
Faxen-Irving et al., 2011, [35] RCT 9/13
Hubbard et al., 2008, [36] RCT 5/13
Irvine et al., 2004, [37] NRES 9/9
Kimura et al., 2013, [38] RCT 9/13
Mathey et al., 2001, [39] RCT 9/13
Pouyssegur et al., 2015, [40] RCT 9/13
Reuben et al., 2005, [41] RCT 13/13
Robison et al., 2014, [42] Qualitative 8/10
Ryan et al., 2004, [43] NRES 9/9
Tylner et al., 2016, [47] RCT 10/13
Wijnhoven et al., 2015, [44] NRES 9/9
Yeh et al., 2000, [45] RCT 13/13
RCT = randomized controlled trial. NRES = non-randomized experimental studies.
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